INSIGHTS ON REGULATORY COMPLIANCE
-
Reflecting Again On GMP Requirements For Marketing Authorization Holder
Learn in detail about Annex 16, the responsibilities of Marketing Authorization Holders (MAHs), and a practical way for MAHs to implement their responsibilities with their contract manufacturers.
-
What Drug Manufacturers Should Know About Operational Readiness
Moving beyond last-minute checklists, true Operational Readiness is about intentionally building success into your facility’s DNA. Discover the foundational elements that enable a smoother and safer startup.
-
Regulatory Compliance And Audits For Parenteral Manufacturing Precision
CMOs play a critical role in regulatory compliance for parenteral manufacturing, using audits, quality systems, and proactive strategies to ensure product safety and patient well-being.
-
Unlocking Audit Success: Navigate Compliance With Confidence
Watch expert Kathianne Ross explore ALCOA+ principles, audit preparation strategies, and the role of digital validation in enhancing compliance and audit success.
-
Handling Protocols: Key Considerations In The Highly Potent API Market5/12/2025
Explore the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.
-
Developing Your Risk-Based Approach To Single-Use System Integrity10/29/2025
Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.
-
Why The Latest E2500-25 Standard Revision Demands Immediate Action9/14/2025
The updated E2500-25 standard transforms pharmaceutical manufacturing with a proactive, risk-based approach, enhancing compliance and accelerating the delivery of therapies to patients.
-
5 Trends Impacting CMOs In 20252/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
5 Drug Manufacturing Trends To Look For In 20251/6/2025
The life sciences industry faces big changes in 2025. Companies must adapt to new regulations, AI, and shifting manufacturing landscapes to stay competitive and drive innovation.
REGULATORY COMPLIANCE SOLUTIONS
-
FMS/BioTrak/Portable/Remote/Environmental Sensors
-
Soybean Casein Digest Broth is the recommended media for use with Biological Indicators. The use of another media may detrimentally affect the outgrowth of spores.
-
Explore growth factors and cytokines for regenerative medicine and cell and gene therapies offered in both GMP and preclinical grades.
-
Explore imaging, fluorescence, and luminescence-based techniques for cell analysis, viability, and gene expression, as well as how multimode readers streamline workflows and enhance data quality.
-
Accelerate biotherapeutic development with a platform that integrates data across CLD, USP, DSP, and analytics, which supports advanced technologies, ensures compliance, and streamlines workflows.